Tim Buckley
Director at BA
Board
About Tim Buckley
Mortimer J. “Tim” Buckley (age 55) is an independent director who joined Boeing’s Board in January 2025; he serves on the Finance Committee and the Governance & Public Policy (GPP) Committee . Buckley is the former Chairman (2019–2024) and CEO (2018–2024) of The Vanguard Group, bringing 25 years of leadership with expertise spanning investment management, financial oversight, cybersecurity, digital technology, and corporate governance .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| The Vanguard Group | Chairman | 2019–2024 | Led firm through market/regulatory change; oversaw culture, strategy, and governance |
| The Vanguard Group | CEO | 2018–2024 | Drove new business lines (advice, ETFs), globalized investment mgmt, advanced cybersecurity and digital capabilities |
| The Vanguard Group | President | 2017–2024 | Senior leadership of firm operations and strategy |
| The Vanguard Group | Chief Investment Officer | 2013–2017 | Oversaw internally managed stock, bond, and money market portfolios and investment research/methodology |
| The Vanguard Group | Head, Retail Investor Group | 2006–2012 | Led retail business growth; client service and distribution focus |
| The Vanguard Group | Chief Information Officer | 2001–2006 | Built systems/applications for clients and investment operations; cybersecurity foundations |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Pfizer, Inc. | Director (current) | Not disclosed | Current public company directorship |
| Financial Industry Regulatory Authority (FINRA) | Director (prior) | Not disclosed | Regulatory/market oversight experience |
| Children’s Hospital of Philadelphia | Board Chair (prior) | Not disclosed | Safety/quality culture leadership |
Board Governance
- Committees: Finance; Governance & Public Policy (GPP) .
- Independence: Determined independent; Boeing states 91% of nominees are independent, with all Aerospace Safety, Audit, Compensation, and GPP members independent per NYSE/SEC standards .
- Tenure on Boeing Board: Director since 2025; joined January 2025 amid ongoing Board refreshment (ninth new independent director since 2019) .
- Attendance: 2024 Board-wide average attendance exceeded 99%; director-specific 2025 attendance for Buckley not yet disclosed .
- GPP Committee scope includes director nominations, independence, stock ownership requirements, conflicts oversight, Board performance evaluations, senior management succession (including CEO search), and governance practices; 2024 activities included leading CEO search and adding Buckley for his investment/technology/governance expertise .
Fixed Compensation
Boeing’s nonemployee director pay program emphasizes alignment via stock units and does not pay meeting fees . 2024 cash and equity components and leadership premiums were as follows.
| Element | Amount | Notes |
|---|---|---|
| Annual cash retainer | $135,000 | Paid quarterly; elective deferral to DSUs or cash account |
| Board Chair retainer | $250,000 | Pro‑rated for partial year service |
| Aerospace Safety Committee Chair | $50,000 | Pro‑rated as applicable |
| Audit Committee Chair | $25,000 | Pro‑rated as applicable |
| Compensation/GPP/Finance Chairs | $20,000 | Pro‑rated as applicable |
| Special Programs Committee Chair | $15,000 | Pro‑rated as applicable |
| Retainer stock units (RSUs/DSUs) | $200,000 (aggregate grant date FV per director in 2024) | Granted quarterly; distribution only after termination of Board service |
| Charitable gift match cap | Up to $31,000/year | Directors derive no financial benefit; listed as “All Other Compensation” where applicable |
| Meeting fees | None | Attendance expected; no per‑meeting fees |
Buckley was appointed in January 2025; his 2024 compensation is not applicable. The program’s structure and amounts above reflect 2024 disclosures .
Performance Compensation
| Component | Status | Details |
|---|---|---|
| Bonuses/Target bonus % | Not applicable | Nonemployee directors do not receive bonuses |
| Performance share units (PSUs) | Not applicable | Director equity is retainer stock units; no PSUs disclosed |
| Options | Not applicable | No option grants to nonemployee directors disclosed |
| Performance metrics (TSR, EBITDA, ESG, etc.) | Not applicable | Director compensation is fixed retainers + stock units; no performance‑based metrics |
Other Directorships & Interlocks
| Company | Relationship | Potential Interlock/Exposure | Notes |
|---|---|---|---|
| Pfizer, Inc. | Current public company board | Customer/supplier exposure not disclosed | Listed as Buckley’s current public board; standard independence framework applied |
| The Vanguard Group | Prior leadership/directorship | Vanguard is a large asset manager; perceived investor ties | Boeing reviews director conflicts; independence affirmed; related‑person transactions governed by GPP processes |
| FINRA; Children’s Hospital of Philadelphia | Prior board roles | Regulatory/quality/safety governance experience | Non‑profit/regulatory boards; enhances oversight skill set |
Expertise & Qualifications
- Engineering/Technology Leadership; Risk Management; Highly Regulated Industry Experience; Cybersecurity/Digital Technology; Human Capital Management; International Leadership; CEO of a Large Company; Senior Leadership Experience .
Equity Ownership
As of February 24, 2025.
| Holder | Shares Beneficially Owned | Stock Units (Deferred) | Total | Ownership % of Outstanding |
|---|---|---|---|---|
| Mortimer J. Buckley | 0 | 480 | 480 | <1% |
- DSUs/retainer stock units are distributed only after termination of Board service; units earn dividend equivalents; directors may elect lump sum or up to 15 annual installments after service ends .
- Stock ownership guidelines: ≥3x annual cash retainer after 3 years of service; ≥5x after 6 years; Boeing states each director currently exceeds their applicable requirement; hedging and pledging of Boeing securities are prohibited .
Governance Assessment
- Independence and committee placement: Buckley is independent and sits on Finance and GPP—two oversight-heavy committees that shape capital allocation, governance standards, director nominations, independence reviews, stock ownership requirements, conflicts screening, and succession planning. This positioning supports board effectiveness in a period of CEO transition and safety/quality remediation .
- Alignment mechanisms: Director equity delivered as retainer stock units with distribution deferred until after board service, plus robust ownership guidelines and anti‑hedging/pledging policies, enhance long-term alignment and reduce short-term trading incentives .
- Engagement/attendance signals: Board-level 2024 attendance topped 99% amid elevated oversight activity; Buckley joined in January 2025, with his individual attendance not yet disclosed. The Board Chair reported intensive stakeholder engagement and a thorough CEO search run by GPP, indicating high director engagement .
- Potential conflicts: Prior leadership at Vanguard (a major institutional investor) and current Pfizer directorship are mitigated by Boeing’s independence determinations and formal related‑person transaction policies (annual questionnaires, GPP review and pre‑approval thresholds, recusal requirements) .
RED FLAGS: None disclosed specific to Buckley. Boeing prohibits hedging/pledging, meeting fees are not paid, and the GPP committee actively oversees conflicts; Buckley’s beneficial common stock holdings were 0 shares as of February 24, 2025, offset by 480 deferred stock units, typical for a newly added director under Boeing’s program .